IT

Indrasingh Thansingh Rajput

Active Director Whole-Time Director DIN 10711854
DIN 10711854 First appointment Jul 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Indrasingh Thansingh Rajput

Data last updated:

Indrasingh Thansingh Rajput is a Whole-Time Director at Indusy Pharma Private Limited (since 2024).

DIN 10711854
Primary Designation Whole-Time Director
First Appointment 19 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indusy Pharma Private Limited U46497GJ2024PTC153581
Whole-Time Director19 Jul 20242024Active

Board colleagues of Indrasingh Thansingh Rajput

NameDINCompanyDesignation
Madhukunwar Indrasingh Rajput10711855Indusy Pharma Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Indusy Pharma Private Limited
Premium access

Shareholding and investment profile for Indrasingh Thansingh Rajput

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Indrasingh Thansingh Rajput

Indrasingh Thansingh Rajput currently holds 1 directorship: Indusy Pharma Private Limited (Whole-Time Director, since 19 Jul 2024).

Indrasingh Thansingh Rajput was first appointed on 19 Jul 2024 as Whole-Time Director at Indusy Pharma Private Limited.

The current boards of Indrasingh Thansingh Rajput's companies include Madhukunwar Indrasingh Rajput (Indusy Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available